Atlas Trials

Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.

Clinical trial NCT00394056 · COMPLETED

Trial details

NCT number
NCT00394056
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Tinnitus
Start date
2006-12-01
Primary completion
2009-08-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.